REL-1017
Showing 1 - 25 of 44
MDD, Depression Trial (REL-1017)
Available
- Major Depressive Disorder
- Depression
- REL-1017
- (no location specified)
Aug 17, 2023
MDD, Depression Trial in United States (REL-1017, Placebo)
Recruiting
- Major Depressive Disorder
- Depression
- REL-1017
- Placebo
-
Culver City, California
- +5 more
Aug 21, 2023
MDD Trial in United States (REL-1017, Placebo)
Recruiting
- Major Depressive Disorder
- REL-1017
- Placebo
-
Saraland, Alabama
- +46 more
Jan 18, 2023
MDD Trial in United States (REL-1017, Placebo)
Recruiting
- Major Depressive Disorder
- REL-1017
- Placebo
-
Phoenix, Arizona
- +57 more
May 9, 2022
MDD Trial in United States (REL-1017, Placebo)
Recruiting
- Major Depressive Disorder
- REL-1017
- Placebo
-
Phoenix, Arizona
- +52 more
Apr 14, 2022
Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in United States (REL-1017, Placebo)
Completed
- Depressive Disorder, Major
- Depressive Disorder, Treatment-Resistant
- REL-1017
- Placebo
-
Little Rock, Arkansas
- +9 more
Mar 16, 2021
MDD Trial in United States (REL-1017)
Recruiting
- Major Depressive Disorder
- REL-1017
-
Saraland, Alabama
- +102 more
Jan 18, 2023
Neuropathic Pain Trial (REL-1017, Placebo)
Completed
- Neuropathic Pain
- REL-1017
- Placebo
- (no location specified)
Jul 30, 2019
Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia Trial in Worldwide (IMI/REL FDC, PIP/TAZ FDC,
Completed
- Hospital-Acquired Bacterial Pneumonia
- Ventilator-Associated Bacterial Pneumonia
- IMI/REL FDC
- +2 more
-
Belo Horizonte, Minas Gerais, Brazil
- +67 more
Jul 19, 2022
Neuropathic Pain Trial (REL-1017, Placebo)
Completed
- Neuropathic Pain
- REL-1017
- Placebo
- (no location specified)
Aug 17, 2018
Community Mental Health Services, Adolescent Well Being, Resilience, Psychological Trial in Cambridge, Everett, Somerville
Recruiting
- Community Mental Health Services
- +4 more
- COPE2Thrive
- Usual care
-
Cambridge, Massachusetts
- +3 more
Dec 20, 2022
Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL, Active Control)
Recruiting
- Suspected or Documented Gram-negative Bacterial Infection
- IMI/REL
- Active Control
-
Tucson, Arizona
- +64 more
Aug 18, 2022
Carbapenem-Resistant Enterobacteriaceae Infection, KPC, Gram-Negative Bacterial Infections Trial in Charlotte
Recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- +3 more
-
Charlotte, North CarolinaCarolinas Medical Center
Jun 16, 2022
Alzheimer, Dementia of Alzheimer Type Trial in Australia, United States (ATH-1017, Placebo)
Completed
- Alzheimer Disease
- Dementia of Alzheimer Type
- ATH-1017
- Placebo
-
Santa Ana, California
- +12 more
Jul 5, 2022
Solid Tumor, Tumors Trial in Lund, Solna, Uppsala (ATOR-1017)
Active, not recruiting
- Solid Tumor
- Neoplasms
- ATOR-1017
-
Lund, Sweden
- +2 more
Aug 16, 2022
Resistance in Carbapenemase-producing Enterobacterales and
Enrolling by invitation
- Bacterial Infections
- Antibiotic Resistant Infection
- No intervention
-
Rio De Janeiro, BrazilD'Or Institute for Research and Education (IDOR)
Mar 16, 2022
Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL FDC)
Completed
- Suspected or Documented Gram-negative Bacterial Infection
- IMI/REL FDC
-
Little Rock, Arkansas
- +32 more
Oct 28, 2021
Parkinson Disease Dementia, Dementia With Lewy Bodies Trial in United States (ATH-1017, Placebo)
Recruiting
- Parkinson Disease Dementia
- Dementia With Lewy Bodies
- ATH-1017
- Placebo
-
Boca Raton, Florida
- +9 more
May 17, 2022
Degenerative Disease of the Lumbosacral Spine Trial in China, United States (Infuse™ Bone Graft (Infuse™), Capstone™ Spinal
Recruiting
- Degenerative Disease of the Lumbosacral Spine
- Infuse™ Bone Graft (Infuse™)
- Intervertebral body fusion device and Medtronic posterior Fixation Systems
-
Phoenix, Arizona
- +40 more
Feb 1, 2023
Periodontitis Trial in Belgrade (Piperacillin and Tazobactam in gel form, Amoxicillin and Metronidazole)
Active, not recruiting
- Periodontitis
- Piperacillin and Tazobactam in gel form
- Amoxicillin and Metronidazole
-
Belgrade, SerbiaDepartment of Periodontology, School of Dental Medicine, Univers
Oct 31, 2022
Gastrointestinal Microbiome Trial in Zagreb (Myrkl, dextrin)
Not yet recruiting
- Gastrointestinal Microbiome
- Myrkl
- dextrin
-
Zagreb, CroatiaGut Microbiome Center
Nov 8, 2023
Healthy Volunteers Trial in Madison ([14C]-Fosgonimeton)
Active, not recruiting
- Healthy Volunteers
-
Madison, WisconsinLabcorp Clinical Research Unit
Aug 19, 2022